About Us
At Aster Insights, we believe that personalized medicine starts with the ability to capture a complete view of an individual across their lifetime. Our company was founded in 2006 on a unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer.
As a long-time innovator in oncology, we have world-class expertise in accelerating the oncology medical product life cycle. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with the leading cancer centers in the United States. We empower researchers and the life sciences industry to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of treatment response, discover indication expansion opportunities, and accelerate clinical trials.
What Sets Us Apart
Aster Insights helps drug, biologics, diagnostics, and medical device developers accelerate oncology product discovery and development through our scientific and clinical intelligence coupled with unparalleled partnership with the Oncology Research Information Exchange Network (ORIEN®). ORIEN® is comprised of leading cancer centers across the United States that provide care for a diverse patient population and deliver an unparalleled breadth of cancer care.
Exceptional Scientific Insights
We deliver scientific and clinical intelligence powered by ORIEN® and TCC® that fuels emerging research and discovery for tomorrow's cures.
Unparalleled Research Consortium
We build comprehensive partnerships between our life sciences partners and the Oncology Research Information Exchange Network (ORIEN®) to accelerate your product development cycle.
Total Cancer Care®: Largest and Longest Running Observational Study in Oncology
We are entrusted with comprehensive consent and indefinite access to patients’ health information, including biospecimens and emerging data modalities, across their healthcare journey.